Swiss National Bank Reduces Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Swiss National Bank lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 357,900 shares of the company’s stock after selling 20,900 shares during the period. Swiss National Bank owned about 0.29% of Henry Schein worth $24,767,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Versant Capital Management Inc boosted its position in Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC boosted its position in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares during the period. Quent Capital LLC boosted its position in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the period. Smartleaf Asset Management LLC boosted its position in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares during the period. Finally, City State Bank purchased a new stake in Henry Schein during the 4th quarter valued at $55,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on HSIC shares. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price for the company. Barrington Research reissued an “outperform” rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Stock Up 1.7 %

Shares of HSIC stock opened at $71.80 on Tuesday. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The stock has a market cap of $8.92 billion, a P/E ratio of 29.55, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50 day simple moving average of $74.84 and a two-hundred day simple moving average of $72.62.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.66 earnings per share. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.